Published 21 hours ago • loading... • Updated 14 hours ago
Popular Thyroid Medication Recalled Nationwide, FDA Warns
The FDA said the Class II recall covers tablets that may cause temporary, reversible health effects in patients with thyroid conditions.
The FDA initiated a nationwide recall for specific lots of levothyroxine sodium tablets distributed by Major Pharmaceuticals due to manufacturing concerns affecting thyroid medication supplies.
Tablets were found to be "subpotent," meaning they deliver less medication than intended, prompting The FDA to designate the recall Class, indicating potential for temporary, reversible health effects.
Affected tablets were packaged in 10-count blister packs, sold individually or bundled into cartons containing 10 packs, allowing consumers to identify recalled lots using specific lot numbers and expiration dates.
Families using thyroid medication should check their medicine cabinets for affected lots, and patients discovering recalled tablets must consult a doctor or pharmacist before taking further action.
Patients should not discontinue medication unless directed by a healthcare provider, as suddenly stopping treatment can cause ill effects, making professional guidance essential for safe management.